Mohamad Sater is the Director of Computational Biology at Day Zero Diagnostics, a healthcare startup spun out of Harvard University to develop a genomic sequencing-based rapid diagnostic for bacterial infections. Dr. Sater received his PhD in Microbiology from the Swiss Institute of Bioinformatics and Basel University, then completed a postdoctoral fellowship at Harvard University. His academic research focused on bacterial mechanisms of antibiotic resistance and persistence. He also developed data analysis methods leveraging whole genome sequencing data and clinical metadata to investigate microbial transmission dynamics and reconstruct outbreaks.
Microbial Profiling Showcase:
Day Zero Diagnostics
Day Zero Diagnostics is an infectious disease diagnostics company using whole-genome sequencing and machine learning to combat the rise of antibiotic-resistant infections.
Definitive Clonality Determination in Hospital-acquired Infection
epiXact: a rapid WGS service that provides hospitals with definitive answers for infection transmission investigations.
Session Abstract – PMWC 2022 Silicon Valley
The PMWC 2022 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Nerodegenerative